We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Psychiatry

Psychiatry

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link
OB/GYN & Women's Healthdepressionhyperemesis gravidarum

Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link

By MedXY|Oct 18, 2025

This comprehensive review examines the recent Finnish study highlighting the complex relationship between hyperemesis gravidarum and depression, emphasizing clinical implications for integrated mental health screening during reproductive ca

Comparative Effectiveness of PTSD Treatments in Primary Care: Insights from a Pragmatic Randomized Trial
Family Medicine & Nutritionprimary carepsychotherapy

Comparative Effectiveness of PTSD Treatments in Primary Care: Insights from a Pragmatic Randomized Trial

By MedXY|Oct 15, 2025

A pragmatic trial comparing SSRIs and written exposure therapy in primary care PTSD treatment found similar effectiveness initially; switching to SNRI was superior to WET augmentation for SSRI nonresponders.

Rising Trends in Stimulant Use Disorder Diagnoses Among Adolescent and Young Adult Medicaid Enrollees: Implications for Clinical Practice
newsADHDadolescents

Rising Trends in Stimulant Use Disorder Diagnoses Among Adolescent and Young Adult Medicaid Enrollees: Implications for Clinical Practice

By MedXY|Oct 15, 2025

Stimulant use disorder diagnoses in young adult Medicaid enrollees have markedly increased from 2001 to 2020, especially for noncocaine psychostimulants, highlighting an urgent need for targeted interventions and evidence-based treatments a

Lithium’s Role in Reducing Suicidal Ideation and Behaviors: An Updated Meta-Analysis of Randomized Controlled Trials
Internal Medicinebipolar disorderlithium

Lithium’s Role in Reducing Suicidal Ideation and Behaviors: An Updated Meta-Analysis of Randomized Controlled Trials

By MedXY|Oct 12, 2025

This systematic review evaluates lithium’s efficacy in reducing suicidal ideation, attempts, and completed suicide, highlighting methodological challenges and the likelihood of benefit despite lack of statistical significance in RCTs.

Predicting Seizure Recurrence After a First Unprovoked Seizure: Key Prognostic Factors and Clinical Implications
NeurologySeizure recurrence

Predicting Seizure Recurrence After a First Unprovoked Seizure: Key Prognostic Factors and Clinical Implications

By MedXY|Oct 12, 2025

This article examines prognostic factors predicting seizure recurrence after a first unprovoked seizure in children and adults, highlighting the roles of EEG abnormalities, brain imaging, nocturnal seizures, and family history, while addres

Understanding Dropout in Digital Psychosocial Interventions for Adult Illicit Substance Users: Insights from a Systematic Review and Meta-Analysis
news

Understanding Dropout in Digital Psychosocial Interventions for Adult Illicit Substance Users: Insights from a Systematic Review and Meta-Analysis

By MedXY|Oct 12, 2025

This meta-analysis examines dropout rates in digital psychosocial interventions for adult illicit drug users, identifying key demographic, clinical, and intervention-related factors associated with treatment adherence.

Decoding the Optimal Aerobic Exercise Dose for Alleviating Depression in Youth: Evidence from a Meta-Analysis
newsadolescentschildren

Decoding the Optimal Aerobic Exercise Dose for Alleviating Depression in Youth: Evidence from a Meta-Analysis

By MedXY|Oct 12, 2025

Aerobic exercise significantly alleviates depressive symptoms in children and adolescents, especially in diagnosed adolescents, with 590 METs-min/week at moderate intensity identified as the optimal dose.

Coenzyme Q10 in Depression and Anxiety: Evaluating Therapeutic Potential Through Meta-Analysis
Internal Medicineanxietydepression

Coenzyme Q10 in Depression and Anxiety: Evaluating Therapeutic Potential Through Meta-Analysis

By MedXY|Oct 12, 2025

This meta-analysis examines Coenzyme Q10 supplementation’s impact on depression and anxiety, revealing modest benefits for depression at low doses and short durations but insufficient evidence for anxiety improvement.

Brexpiprazole in Alzheimer’s Disease-Related Agitation: Modest Gains Amidst Safety Uncertainties
NeurologyagitationAlzheimer's disease

Brexpiprazole in Alzheimer’s Disease-Related Agitation: Modest Gains Amidst Safety Uncertainties

By MedXY|Oct 12, 2025

This review evaluates brexpiprazole’s efficacy and safety for agitation in Alzheimer’s disease, revealing modest symptom improvement but uncertain safety profiles, underscoring the need for individualized therapy and further res

Which Mental-Health Steps Should Trauma Teams Prioritize? A Practical Synthesis of New Guideline Recommendations
Emergency Medicineclinical practice guidelinesPTSD

Which Mental-Health Steps Should Trauma Teams Prioritize? A Practical Synthesis of New Guideline Recommendations

By MedXY|Oct 10, 2025

A systematic synthesis of clinical practice guideline recommendations for preventing and managing mental disorders after traumatic injury, with prioritized, implementable actions for acute and early recovery care.

Delays in Pediatric Cannabis Toxicology Testing Lead to Increased Neuroimaging in Emergency Departments
Emergency MedicineNeuroimagingpediatric emergency

Delays in Pediatric Cannabis Toxicology Testing Lead to Increased Neuroimaging in Emergency Departments

By MedXY|Oct 9, 2025

Delayed cannabis test results in children under 6 with poisoning symptoms prolong ED visits and influence neuroimaging use. Faster toxicology screening could optimize care and reduce unnecessary scans.

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Four-Year Randomized Clinical Trial Review
Psychiatryfunctional outcomesRelapse Risk

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Four-Year Randomized Clinical Trial Review

By MedXY|Oct 6, 2025

This review synthesizes evidence from a large randomized trial comparing early antipsychotic dose reduction/discontinuation versus maintenance after first-episode psychosis remission, emphasizing short-term risks and long-term functional ga

Balancing Risks and Benefits: Early Antipsychotic Dose Reduction Versus Maintenance After First-Episode Psychosis Remission
Clinical Updatesantipsychoticsdose reduction

Balancing Risks and Benefits: Early Antipsychotic Dose Reduction Versus Maintenance After First-Episode Psychosis Remission

By MedXY|Oct 6, 2025

A randomized clinical trial reveals early dose reduction of antipsychotics after first-episode psychosis remission increases short-term relapse risk and lowers quality of life, but may improve long-term functioning over four years.

Heart Rate Variability Biofeedback in Substance Use Disorder: Emerging Evidence from a Randomized Clinical Trial and Contextual Review
Clinical Updatesrandomized clinical trialsubstance use disorder

Heart Rate Variability Biofeedback in Substance Use Disorder: Emerging Evidence from a Randomized Clinical Trial and Contextual Review

By MedXY|Oct 6, 2025

Second-generation heart rate variability biofeedback (HRVB) shows promise in reducing craving, negative affect, and substance use in adults with substance use disorder (SUD), supporting its potential as an adjunctive treatment in early reco

Unraveling ADHD: Gut Microbial Signatures and the Role of SCFA Deficiency in Symptom Pathogenesis
NeurologyADHDgut microbiota

Unraveling ADHD: Gut Microbial Signatures and the Role of SCFA Deficiency in Symptom Pathogenesis

By MedXY|Oct 6, 2025

Recent research reveals distinct gut microbial and metabolic profiles linked to ADHD symptoms, highlighting short-chain fatty acid deficiency as a key mechanism driving hyperactivity and inattention.

Restoring Cognitive Function After Adolescent Alcohol Exposure: The Promise of Synbiotic Therapy Targeting the Microbiota-Gut-Brain Axis
Medical News

Restoring Cognitive Function After Adolescent Alcohol Exposure: The Promise of Synbiotic Therapy Targeting the Microbiota-Gut-Brain Axis

By MedXY|Sep 30, 2025

A synbiotic intervention reverses alcohol-induced cognitive deficits in adolescent mice by modulating gut microbiota and brain metabolism, suggesting potential therapeutic avenues for alcohol-related neurobehavioral impairments.

Soft Drink Consumption and Depression: The Gut Microbiome Connection, Especially Eggerthella
Family Medicine & Nutritiongut microbiomemajor depressive disorder

Soft Drink Consumption and Depression: The Gut Microbiome Connection, Especially Eggerthella

By MedXY|Oct 9, 2025

This analysis explores how soft drink consumption correlates with major depressive disorder (MDD), revealing gut microbiome alterations—particularly in Eggerthella abundance—that may mediate this association, highlighting potential interven

Cytisinicline Enhances Smoking Cessation in COPD Patients: Post Hoc Insights from the ORCA-2 and ORCA-3 Trials
newsclinical trialCOPD

Cytisinicline Enhances Smoking Cessation in COPD Patients: Post Hoc Insights from the ORCA-2 and ORCA-3 Trials

By MedXY|Oct 9, 2025

Cytisinicline significantly improves smoking cessation rates and is well tolerated in smokers with self-reported COPD, supporting its use as an effective treatment option for this high-risk population.

Childhood Loneliness: A Lasting Risk Factor for Cognitive Decline and Dementia in Later Life
Clinical Updatescognitive declinedementia risk

Childhood Loneliness: A Lasting Risk Factor for Cognitive Decline and Dementia in Later Life

By MedXY|Oct 9, 2025

Childhood loneliness significantly increases the risk of cognitive decline and dementia in middle-aged and older adults, independent of adult loneliness, highlighting the importance of early psychosocial interventions.

Brain Connectome Modulates the Impact of Adverse Childhood Experiences on Mental Health in Preadolescents
newsAdverse Childhood ExperiencesFunctional Connectivity

Brain Connectome Modulates the Impact of Adverse Childhood Experiences on Mental Health in Preadolescents

By MedXY|Oct 9, 2025

This cohort study reveals that whole-brain functional connectivity alters the link between adverse childhood experiences and psychiatric disorders in children, particularly for threat-related exposures and females, suggesting a neurobiologi

Prev
15 / 20
1…1314151617…20
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles